Fehm T - Search Results

1

Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" Trial.

Riethdorf S, Müller V, Loibl S, Nekljudova V, Weber K, Huober J, Fehm T, Schrader I, Hilfrich J, Holms F, Tesch H, Schem C, von Minckwitz G, Untch M, Pantel K. Riethdorf S, et al. Among authors: fehm t. Clin Cancer Res. 2017 Sep 15;23(18):5384-5393. doi: 10.1158/1078-0432.CCR-17-0255. Epub 2017 Jul 5. Clin Cancer Res. 2017. PMID: 28679772

2

Influence of circulating c-erbB-2 serum protein on response to adjuvant chemotherapy in node-positive breast cancer patients.

Fehm T, Maimonis P, Weitz S, Teramoto Y, Katalinic A, Jäger W. Fehm T, et al. Breast Cancer Res Treat. 1997 Mar;43(1):87-95. doi: 10.1023/a:1005700812422. Breast Cancer Res Treat. 1997. PMID: 9065602

3

The prognostic significance of c-erbB-2 serum protein in metastatic breast cancer.

Fehm T, Maimonis P, Katalinic A, Jäger WH. Fehm T, et al. Oncology. 1998 Jan-Feb;55(1):33-8. doi: 10.1159/000011832. Oncology. 1998. PMID: 9428373

4

Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.

Fehm T, Sagalowsky A, Clifford E, Beitsch P, Saboorian H, Euhus D, Meng S, Morrison L, Tucker T, Lane N, Ghadimi BM, Heselmeyer-Haddad K, Ried T, Rao C, Uhr J. Fehm T, et al. Clin Cancer Res. 2002 Jul;8(7):2073-84. Clin Cancer Res. 2002. PMID: 12114406

5

Prognostic significance of serum HER2 and CA 15-3 at the time of diagnosis of metastatic breast cancer.

Fehm T, Jäger W, Krämer S, Sohn C, Solomayer E, Wallwiener D, Gebauer G. Fehm T, et al. Anticancer Res. 2004 May-Jun;24(3b):1987-92. Anticancer Res. 2004. PMID: 15274389 Free article.

6

Circulating tumor cells in patients with breast cancer dormancy.

Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, Beitsch PD, Leitch M, Hoover S, Euhus D, Haley B, Morrison L, Fleming TP, Herlyn D, Terstappen LW, Fehm T, Tucker TF, Lane N, Wang J, Uhr JW. Meng S, et al. Among authors: fehm t. Clin Cancer Res. 2004 Dec 15;10(24):8152-62. doi: 10.1158/1078-0432.CCR-04-1110. Clin Cancer Res. 2004. PMID: 15623589

7

A pooled analysis of bone marrow micrometastasis in breast cancer.

Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC, Schlimok G, Diel IJ, Gerber B, Gebauer G, Pierga JY, Marth C, Oruzio D, Wiedswang G, Solomayer EF, Kundt G, Strobl B, Fehm T, Wong GY, Bliss J, Vincent-Salomon A, Pantel K. Braun S, et al. Among authors: fehm t. N Engl J Med. 2005 Aug 25;353(8):793-802. doi: 10.1056/NEJMoa050434. N Engl J Med. 2005. PMID: 16120859 Free article.

8

Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy.

Becker S, Becker-Pergola G, Wallwiener D, Solomayer EF, Fehm T. Becker S, et al. Among authors: fehm t. Breast Cancer Res Treat. 2006 May;97(1):91-6. doi: 10.1007/s10549-005-9095-6. Epub 2005 Dec 1. Breast Cancer Res Treat. 2006. PMID: 16319975

9

Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients.

Solomayer EF, Becker S, Pergola-Becker G, Bachmann R, Krämer B, Vogel U, Neubauer H, Wallwiener D, Huober J, Fehm TN. Solomayer EF, et al. Breast Cancer Res Treat. 2006 Jul;98(2):179-84. doi: 10.1007/s10549-005-9147-y. Epub 2006 Mar 22. Breast Cancer Res Treat. 2006. PMID: 16552629

10

A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation.

Fehm T, Braun S, Muller V, Janni W, Gebauer G, Marth C, Schindlbeck C, Wallwiener D, Borgen E, Naume B, Pantel K, Solomayer E. Fehm T, et al. Cancer. 2006 Sep 1;107(5):885-92. doi: 10.1002/cncr.22076. Cancer. 2006. PMID: 16874814 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

570 results

Search Page